About Bectas Therapeutics
Bectas Therapeutics is a private company based in Houston, Texas, incorporated in 2022 in Delaware. It has reported $5,550,000 raised in one offering on Form D since October 2024. Its chief executive is Ronan O'Hagan.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 21, 2022 | Oct 9, 2024amended Oct 8, 2025 | $5,550,000of $10.0M target | 13 | $426K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Bectas Therapeutics's Form D filed Oct 8, 2025.